Loading...
Goodness Growth Holdings, Inc.
GDNS.CN•CNQ
Healthcare
Drug Manufacturers - Specialty & Generic
CA$0.63
CA$0.00(0.00%)

Financial performance has remained strong, with revenue growing from $20.20M in Q2 2023 to $23.98M in Q1 2024. Gross profit continued to perform well, with margins at 50% in the latest quarter. Operating income reached $4.74M in Q1 2024, holding a steady 20% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $4.99M. Net income dropped to -$6.68M, keeping EPS at -$0.05. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan